A genetically modified pig kidney has functioned inside a living patient for a record nine months, successfully serving as a temporary bridge to a subsequent human donor transplant for the first time...
A CRISPR-based therapy continues to reduce harmful cholesterol levels in patients after a one-year follow-up in a Phase 1 clinical trial...
Dr Tom Turner explores Professor Jennifer Doudna's reflections on the discovery of CRISPR and the future of genome editing in this conversation, which examines one of the most transformative advances in modern biology…
Artificial intelligence has been used to design functional viruses from scratch for the first time...
A comprehensive biobank of patient-derived tumour organoids has been developed to map genes that cancer cells depend on for growth and survival...
A six-year-old girl has died following an experimental genome editing treatment, prompting an investigation into the clinical trial by the university involved...
Behind every scientific breakthrough is a story. Dr Oliver Bower, the lead author of a recent Nature study, describes how listening to people affected by genetic disease reshaped his research and his perspective on the future of genome editing...
Donor stem cells that underwent a precise type of genome editing could pave the way for safer, chemotherapy-free transplants, new results in mice show...
Professor Karen Sermon and Sarah Norcross explain why ESHRE and PET have collaborated to publish the wide-ranging report 'Fertility, Embryo Research and Genome Editing: Public Attitudes in Europe'...
The PET team discusses findings from a PET/ESHRE report exploring attitudes to fertility treatment, embryo research, genome editing, donor conception, surrogacy and related topics in the UK, the Netherlands, Spain and Italy...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
